EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
2 08-2022

Sir Colin Blakemore (1944-2022): A Tribute

2022-08-02T15:37:05+00:0002-08-2022|News|

Neuroscientist, outstanding science communicator, advocate of animal rights, rationality and openness. The Observer described Blakemore as one of the UK's most influential scientists and a determined and courageous opponent of the violence of the animal rights movement. Colin, despite threats to himself and his family, including a parcel bomb opened by his children [...]

13 07-2022

Event Report: EBC at FENS Forum 2022

2022-07-18T13:07:38+00:0013-07-2022|News|

EBC was pleased to be back to another in-person congress last week, attending the FENS Forum on 9-13 July in Paris, France. EBC had a series of events throughout the five days, including a permanent stand in the Exhibition Hall, which brought a lot of interest and saw many EBC materials and giveaways distributed to [...]

23 06-2022

Preparing Europe for Novel Psychedelic-Assisted Therapies: PAREA officially launched on 23 June 2022

2022-06-24T10:24:15+00:0023-06-2022|News|

The Psychedelic Access and Research European Alliance – PAREA was officially launched today at a virtual event. Keynote Address was delivered by Dr Thomas Insel, former Director of the US National Institute of Mental Health (2002 – 2015). Other speakers included representatives from the European Parliament, European Commission, European Medicines Agency, patients and organizations representing [...]

16 06-2022

Season 2 of Brain Talks podcast launched

2022-07-01T09:25:19+00:0016-06-2022|News|

Brain Talks is a podcast produced by the Brain Innovation Days — a key EBC project — featuring key opinion leaders and stakeholders from the ever-growing brain ecosystem, discussing the latest breakthroughs, ongoing research and other exciting topics related to brain innovation. The first season was launched in 2021, with brilliant speakers from the [...]

9 06-2022

The European Brain Council launches “Migraine, my brain” campaign to rethink migraine care

2022-06-17T16:02:06+00:0009-06-2022|News|

On the occasion of Migraine & Headache Awareness Month, the European Brain Council launches "Migraine, my brain" campaign to highlight the need to rethink migraine care. The campaign falls under  "RETHINKING Migraine in times of COVID-19", a research-driven project offering tangible policy changes to improve the lives of people living with migraine across Europe. [...]

29 05-2022

Neurological disorders become a major global health priority

2022-05-31T13:37:30+00:0029-05-2022|News|

Supporting the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders The members of the OneNeurology partnership celebrate a major milestone for all those affected by neurological disorders today, with the adoption of the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders, announced at last week’s 75th World Health Assembly. We fully [...]

24 05-2022

RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!

2022-05-24T07:55:53+00:0024-05-2022|News|

Through RETHINKING Alzheimer’s disease (AD), the European Brain Council (EBC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) are joining forces with the ambition of improving Alzheimer’s disease care pathway and the lives of people living with it. Officially launched on 29 April 2022, the project kicked off its operational activities with [...]

25 04-2022

Visit the extended exhibition “Living with MS during COVID-19: A case for rethinking MS care in the EU”

2022-04-25T08:32:05+00:0025-04-2022|News|

On the occasion of Multiple Sclerosis Awareness Week 2022, the national extension of the virtual exhibition "Living with MS during COVID-19: A case for rethinking MS care in the EU" brings light to the impact of the COVID-19 pandemic on multiple sclerosis at country level. Impact of the COVID-19 pandemic on multiple sclerosis at [...]

Go to Top